Cargando…

Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose

BACKGROUND: The purpose of this study was to evaluate intestinal absorption, organ distribution, and urinary elimination of the rare sugar D-psicose, a 3-carbon stereoisomer of D-fructose that is currently being investigated and which has been found to be strongly effective against hyperglycemia and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukamoto, Ikuko, Hossain, Akram, Yamaguchi, Fuminori, Hirata, Yuko, Dong, Youyi, Kamitori, Kazuyo, Sui, Li, Nonaka, Machiko, Ueno, Masaki, Nishimoto, Kazuyuki, Suda, Hirofumi, Morimoto, Kenji, Shimonishi, Tsuyoshi, Saito, Madoka, Song, Tao, Konishi, Ryoji, Tokuda, Masaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207542/
https://www.ncbi.nlm.nih.gov/pubmed/25378908
http://dx.doi.org/10.2147/DDDT.S60247
_version_ 1782340986226081792
author Tsukamoto, Ikuko
Hossain, Akram
Yamaguchi, Fuminori
Hirata, Yuko
Dong, Youyi
Kamitori, Kazuyo
Sui, Li
Nonaka, Machiko
Ueno, Masaki
Nishimoto, Kazuyuki
Suda, Hirofumi
Morimoto, Kenji
Shimonishi, Tsuyoshi
Saito, Madoka
Song, Tao
Konishi, Ryoji
Tokuda, Masaaki
author_facet Tsukamoto, Ikuko
Hossain, Akram
Yamaguchi, Fuminori
Hirata, Yuko
Dong, Youyi
Kamitori, Kazuyo
Sui, Li
Nonaka, Machiko
Ueno, Masaki
Nishimoto, Kazuyuki
Suda, Hirofumi
Morimoto, Kenji
Shimonishi, Tsuyoshi
Saito, Madoka
Song, Tao
Konishi, Ryoji
Tokuda, Masaaki
author_sort Tsukamoto, Ikuko
collection PubMed
description BACKGROUND: The purpose of this study was to evaluate intestinal absorption, organ distribution, and urinary elimination of the rare sugar D-psicose, a 3-carbon stereoisomer of D-fructose that is currently being investigated and which has been found to be strongly effective against hyperglycemia and hyperlipidemia. METHODS: This study was performed using radioactive D-psicose, which was synthesized enzymatically from radioactive D-allose. Concentrations in whole blood, urine, and organs were measured at different time points until 2 hours after both oral and intravenous administrations and 7 days after a single oral administration (100 mg/kg body weight) to Wistar rats. Autoradiography was also performed by injecting 100 mg/kg body weight of (14)C-labeled D-psicose or glucose intravenously to C3H mice. RESULTS: Following oral administration, D-psicose easily moved to blood. The maximum blood concentration (48.5±15.6 μg/g) was observed at 1 hour. Excretion to urine was 20% within 1 hour and 33% within 2 hours. Accumulation to organs was detected only in the liver. Following intravenous administration, blood concentration was decreased with the half-life=57 minutes, and the excretion to urine was up to almost 50% within 1 hour. Similarly to the results obtained with oral administration, accumulation to organs was detected only in the liver. Seven days after the single-dose oral administration, the remaining amounts in the whole body were less than 1%. Autoradiography of mice showed results similar to those in rats. High signals of (14)C-labeled D-psicose were observed in liver, kidney, and bladder. Interestingly, no accumulation of D-psicose was observed in the brain. CONCLUSION: D-psicose was absorbed well after oral administration and eliminated rapidly after both oral and intravenous administrations, with short duration of action. The study provides valuable pharmacokinetic data for further drug development of D-psicose. Because the findings were mainly based on animal study, it is necessary to implement human trials to study the metabolism pathway, which would give an important guide for human intake and food application of D-psicose.
format Online
Article
Text
id pubmed-4207542
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-42075422014-11-06 Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose Tsukamoto, Ikuko Hossain, Akram Yamaguchi, Fuminori Hirata, Yuko Dong, Youyi Kamitori, Kazuyo Sui, Li Nonaka, Machiko Ueno, Masaki Nishimoto, Kazuyuki Suda, Hirofumi Morimoto, Kenji Shimonishi, Tsuyoshi Saito, Madoka Song, Tao Konishi, Ryoji Tokuda, Masaaki Drug Des Devel Ther Original Research BACKGROUND: The purpose of this study was to evaluate intestinal absorption, organ distribution, and urinary elimination of the rare sugar D-psicose, a 3-carbon stereoisomer of D-fructose that is currently being investigated and which has been found to be strongly effective against hyperglycemia and hyperlipidemia. METHODS: This study was performed using radioactive D-psicose, which was synthesized enzymatically from radioactive D-allose. Concentrations in whole blood, urine, and organs were measured at different time points until 2 hours after both oral and intravenous administrations and 7 days after a single oral administration (100 mg/kg body weight) to Wistar rats. Autoradiography was also performed by injecting 100 mg/kg body weight of (14)C-labeled D-psicose or glucose intravenously to C3H mice. RESULTS: Following oral administration, D-psicose easily moved to blood. The maximum blood concentration (48.5±15.6 μg/g) was observed at 1 hour. Excretion to urine was 20% within 1 hour and 33% within 2 hours. Accumulation to organs was detected only in the liver. Following intravenous administration, blood concentration was decreased with the half-life=57 minutes, and the excretion to urine was up to almost 50% within 1 hour. Similarly to the results obtained with oral administration, accumulation to organs was detected only in the liver. Seven days after the single-dose oral administration, the remaining amounts in the whole body were less than 1%. Autoradiography of mice showed results similar to those in rats. High signals of (14)C-labeled D-psicose were observed in liver, kidney, and bladder. Interestingly, no accumulation of D-psicose was observed in the brain. CONCLUSION: D-psicose was absorbed well after oral administration and eliminated rapidly after both oral and intravenous administrations, with short duration of action. The study provides valuable pharmacokinetic data for further drug development of D-psicose. Because the findings were mainly based on animal study, it is necessary to implement human trials to study the metabolism pathway, which would give an important guide for human intake and food application of D-psicose. Dove Medical Press 2014-10-17 /pmc/articles/PMC4207542/ /pubmed/25378908 http://dx.doi.org/10.2147/DDDT.S60247 Text en © 2014 Tsukamoto et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Tsukamoto, Ikuko
Hossain, Akram
Yamaguchi, Fuminori
Hirata, Yuko
Dong, Youyi
Kamitori, Kazuyo
Sui, Li
Nonaka, Machiko
Ueno, Masaki
Nishimoto, Kazuyuki
Suda, Hirofumi
Morimoto, Kenji
Shimonishi, Tsuyoshi
Saito, Madoka
Song, Tao
Konishi, Ryoji
Tokuda, Masaaki
Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose
title Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose
title_full Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose
title_fullStr Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose
title_full_unstemmed Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose
title_short Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose
title_sort intestinal absorption, organ distribution, and urinary excretion of the rare sugar d-psicose
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207542/
https://www.ncbi.nlm.nih.gov/pubmed/25378908
http://dx.doi.org/10.2147/DDDT.S60247
work_keys_str_mv AT tsukamotoikuko intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT hossainakram intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT yamaguchifuminori intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT hiratayuko intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT dongyouyi intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT kamitorikazuyo intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT suili intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT nonakamachiko intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT uenomasaki intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT nishimotokazuyuki intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT sudahirofumi intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT morimotokenji intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT shimonishitsuyoshi intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT saitomadoka intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT songtao intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT konishiryoji intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose
AT tokudamasaaki intestinalabsorptionorgandistributionandurinaryexcretionoftheraresugardpsicose